By vgreene, 9 September, 2015 BSE not recommended d/t lack of evidence for clear benefit (ACOG,14 ACS15) and risk of harm from false-positives (ACOG14)
By vgreene, 9 September, 2015 However, NCCN12 recommends CBE (encounter8) q1-3y for pts 25-39, as does ACOG13 in the context of shared, informed decision-making approach
By vgreene, 9 September, 2015 CBE not recommended d/t lack of evidence (ACP,9 ACS10); insufficient evidence to assess benefits/harms (NCI,11 USPSTF6)
By vgreene, 9 September, 2015 Screening mammography generally not recommended for average risk1 3 pts